Phase 3Completed
Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device
- Sponsor
- Fenwal, Inc. (Industry)
- Enrollment
- 37 enrolled
- Conditions
- Autoimmune Diseases; Renal Disorders; Hematologic Disorders; Oncologic Disorders
- Interventions
- Therapeutic plasma exchange
- Ages
- adults, older adults
- Registry
- NCT01210716
Full record on ClinicalTrials.gov
From the registry
This study will evaluate the use of the AMICUS device in patients where Therapeutic Plasma Exchange (TPE) is prescribed by their physicians.
Primary outcomes
- Percent Efficiency of Plasma Removal During the Therapeutic Plasma Exchange Procedure
History
Results first posted
Last registry update
Primary completion
Registered
Started